Charles River Associates, a provider of economic, financial, and management consulting services, completed the acquisition of bioStrategies, a consulting firm focused on developing commercial strategies. Financial terms were not disclosed. “I am pleased to welcome Mike, Chris and the larger bioStrategies team to CRA in what is an exciting and complementary acquisition for CRA and our Life Sciences Practice. For more than 25 years, our global team of consultants has helped life sciences firms by providing cross-functional support across industry stakeholders and geographies to address core business issues," Paul Maleh, CRA President and CEO.